Latest Coronavirus Disease COVID 19 News and Research
Developing a COVID-19 antigen test
News-Medical speaks to Alastair Smith, the CEO of Avacta, about the process behind their newly developed antigen test for COVID-19.
As Congress weighs COVID liability protections, states shield health providers
Coronavirus patients and their families who believe a doctor, nurse, hospital or other provider made serious mistakes during their care may face a new hurdle if they try to file medical malpractice lawsuits.
Chasing the elusive dream of a COVID cure
Although scientists and stock markets have celebrated the approval for emergency use of remdesivir to treat COVID-19, a cure for the disease that has killed nearly 260,000 people remains a long way off — and might never arrive.
First cellular immunology data to help guide social distancing recommendations
Scientists around the world are racing to develop a vaccine to protect against COVID-19 infection, and epidemiologists are trying to predict how the coronavirus pandemic will unfold until such a vaccine is available.
Chest X-rays can help predict covid-19 severity in young and middle-aged adults
Chest X-rays performed on young and middle-aged adults with COVID-19 when they arrive at the emergency room can help doctors predict who is at higher risk of severe illness and intubation, Mount Sinai researchers report
More research is needed to determine if fecal matter spreads COVID-19, say researchers
Early studies show evidence of COVID-19 genetic material in fecal matter, but more work is needed to determine if the virus can be spread through stool, according to a new review paper from a Rice University epidemiologist.
HVTN and HPTN initiate first clinical trial in response to COVID-19
The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19.
Hot temperatures, air pressure, UV radiation may decrease COVID-19 incidence
A new scientific paper published on the preprint server medRxiv shows that the spread of COVID-19, the respiratory illness that has spread across the world to kill hundreds of thousands in 2020, shows that weather conditions reduce the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Tissue Solutions and CBSB join forces to increase COVID-19 sample availability
The UK’s leading supplier of human tissue samples is joining forces with a Cambridge Biobank to provide COVID-19 samples for scientists.
Research investigates COVID-19 virus origin using artificial intelligence (AI)
The coronavirus responsible for the COVID-19 pandemic has spread across the globe with unprecedented speed and lethality, killing hundreds of thousands of people and forcing countries’ entire populations to self-quarantine.
Mental health of 41% of people in the UK is at risk, study reveals
An international study, led by the Universitat Oberta de Catalunya (Spain) spin-off Open Evidence, has revealed that the mental health of 41% of the UK population is at risk as a result of the coronavirus crisis.
Community knowledge about antibiotics key to fighting against 'superbug' threat
With predictions that drug-resistant ‘superbugs’ could cause up to 10 million deaths a year by 2050, a new CSIRO survey has revealed a low level of community knowledge about antibiotics.
Importance of detecting neutralizing antibody response in recovered COVID-19 patients
In an article published today in Cell Host and Microbe, Professor Kanta Subbarao stressed the importance of detecting a neutralizing antibody response in recovered COVID-19 patients, and of studies of COVID-19 vaccines in animal models.
Viral shedding among pre-symptomatic COVID-19 patients finds study
Researchers from Bangalore, India, have found that 68 percent of pre-symptomatic patients with COVID-19 may be shedding the virus and potentially infecting others. Their study titled, “Quantitative COVID-19 infectiousness estimate correlating with viral shedding and culturability suggests 68% pre-symptomatic transmissions,” was published on the open-access preprint server Medrxiv.
Viral shedding seen in plasma donors who have recovered from COVID-19
Researchers from the University of Wisconsin-Madison have found that plasma donors who have recovered from the deadly COVID-19 infection were still shedding viral RNA. This could be significant they write in their article titled, “Prolonged viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors,” that is published on the preprint server Medrxiv* prior to peer review.
BGU researcher develops one-minute COVID-19 breath test
Ben-Gurion University of the Negev's Prof. Gabby Sarusi has developed and is now validating a test that identifies carriers of the COVID-19 virus in less than a minute with greater than 90% accuracy and at a dramatically lower price than any other method available.
A road map to find unanswered questions about COVID-19
There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.
TUM researchers develop innovative x-ray method for lung diagnostics
Researchers at the Technical University of Munich have developed an innovative x-ray method for lung diagnostics, which they now plan to test in one of its first applications for diagnosis of the respiratory ailment COVID-19 caused by Coronavirus.
Antiviral agent accelerates virus clearance in cases of COVID-19
A team of researchers from have found an antiviral therapy that seems to be an effective treatment for patients with moderate coronavirus disease 2019 (COVID-19).
Does vitamin D deficiency increase COVID-19 risk?
A new paper published on the preprint server medRxiv* in May 2020 reports the first evidence that vitamin D deficiency and inadequate treatment could increase the chances of testing positive for COVID-19. This could shape the way for screening individuals at risk for vitamin D deficiency.
No hay comentarios:
Publicar un comentario